Literature DB >> 7077124

Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids.

F Kern, G T Everson, B DeMark, C McKinley, R Showalter, D Z Braverman, P Szczepanik-Van Leeuwen, P D Klein.   

Abstract

Individuals who take contraceptive steroids or estrogens are at increased risk of developing cholesterol gallstones. The mechanisms of the increased stone formation are incompletely understood. In this study we report biliary lipid composition and secretion, bile acid composition and kinetics, and gallbladder function in a group of healthy, nonobese women taking a contraceptive steroid preparation. A comparable group of healthy women served as controls. Bile-rich duodenal fluid was obtained after stimulation of gallbladder contraction; bile acid, phospholipid, and cholesterol concentrations were determined. Biliary lipid secretion rate was measured by the marker perfusion technique. Bile acid distribution was determined by gas-liquid chromatography. The pool size, FTR, and synthesis rate of each bile acid were measured by using CA and CDCA labeled with the stable isotope of carbon, 13C. In some of the subjects gallbladder storage and emptying were measured during the kinetic study, by real-time ultrasonography. Contraceptive steroid use was associated with a significant increase in biliary cholesterol saturation and in the lithogenic index of bile. The rate of cholesterol secretion in the contraceptive steroid group was 50% greater than in the control (p much less than 0.001) and the rate of bile acid secretion was reduced (p less than 0.02). The total bile acid pool size was significantly increased by contraceptive steroids. The major increase occurred in the CA pool (p less than 0.04). The daily rate of enterohepatic cycles of the bile acid pool was decreased by contraceptive steroids from 6.6 to 4.3 (p less than 0.01). The only effect of contraceptive steroids on gallbladder function was a slower emptying rate in response to intraduodenal amino acid infusion. No index of gallbladder function correlated significantly with any parameter of bile acid kinetics in this small group of subjects. The findings confirm the lithogenic effect of contraceptive steroids and indicate that its causes are an increase in cholesterol secretion and a decrease in bile acid secretion.

Entities:  

Keywords:  Age Factors; Biology; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Diseases; Family Planning; Gallbladder Diseases; Lipid Metabolic Effects--analysis; Lipids; Mestranol; Norethindrone; Oral Contraceptives--side effects; Physiology; Statistical Regression

Mesh:

Substances:

Year:  1982        PMID: 7077124

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  12 in total

1.  Regulation of biliary cholesterol secretion. Functional relationship between the canalicular and sinusoidal cholesterol secretory pathways in the rat.

Authors:  F Nervi; I Marinović; A Rigotti; N Ulloa
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

2.  Oral contraceptives and the risk of gallbladder disease: a meta-analysis.

Authors:  C Thijs; P Knipschild
Journal:  Am J Public Health       Date:  1993-08       Impact factor: 9.308

3.  Associations between reproductive factors and biliary tract cancers in women from the Biliary Tract Cancers Pooling Project.

Authors:  Sarah S Jackson; Hans-Olov Adami; Gabriella Andreotti; Laura E Beane-Freeman; Amy Berrington de González; Julie E Buring; Gary E Fraser; Neal D Freedman; Susan M Gapstur; Gretchen Gierach; Graham G Giles; Francine Grodstein; Patricia Hartge; Mazda Jenab; Victoria Kirsh; Synnove F Knutsen; Qing Lan; Susanna C Larsson; I-Min Lee; Mei-Hsuan Lee; Linda M Liao; Roger L Milne; Kristine R Monroe; Marian L Neuhouser; Katie M O'Brien; Jessica L Petrick; Mark P Purdue; Thomas E Rohan; Sven Sandin; Dale P Sandler; Norie Sawada; Aladdin H Shadyab; Tracey G Simon; Rashmi Sinha; Rachael Stolzenberg-Solomon; Shoichiro Tsugane; Elisabete Weiderpass; Alicja Wolk; Hwai-I Yang; Wei Zheng; Katherine A McGlynn; Peter T Campbell; Jill Koshiol
Journal:  J Hepatol       Date:  2020-05-11       Impact factor: 25.083

4.  Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy.

Authors:  Radha K Dhiman; Pralay K Sarkar; Arpita Sharma; Kala Vasishta; Krishan K Kohli; Sanjay Gupta; Sudha Suri; Yogesh Chawla
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

5.  Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism.

Authors:  G T Everson; C McKinley; F Kern
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

6.  Reproductive factors and risks of biliary tract cancers and stones: a population-based study in Shanghai, China.

Authors:  G Andreotti; L Hou; Y-T Gao; L A Brinton; A Rashid; J Chen; M-C Shen; B-S Wang; T-Q Han; B-H Zhang; L C Sakoda; J F Fraumeni; A W Hsing
Journal:  Br J Cancer       Date:  2010-03-09       Impact factor: 7.640

Review 7.  Hepatobiliary complications of oral contraceptives.

Authors:  M C Lindberg
Journal:  J Gen Intern Med       Date:  1992 Mar-Apr       Impact factor: 5.128

8.  Influence of common bile duct cannula size on maximal secretory rate of taurocholate in the rat.

Authors:  J Reichen; M Le
Journal:  Experientia       Date:  1984-06-15

Review 9.  Drug-induced gallbladder disease. Incidence, aetiology and management.

Authors:  P P Michielsen; H Fierens; Y M Van Maercke
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

10.  The deletion of the estrogen receptor α gene reduces susceptibility to estrogen-induced cholesterol cholelithiasis in female mice.

Authors:  Ornella de Bari; Helen H Wang; Piero Portincasa; Min Liu; David Q-H Wang
Journal:  Biochim Biophys Acta       Date:  2015-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.